Quick Order Cart

Cat. No. ARG39340

DNAJC7 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

DNAJC7 Knockout HAP1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout cell population for studying DNAJC7 co-chaperone function in a human haploid background. Disruption of DNAJC7 impairs HSP70/HSP90-mediated folding of steroid receptors and kinases, with known interactions involving HSPA8 and HSP90AA1. The near-haploid HAP1 cell line provides a fully penetrant knockout model ideal for functional genomics, drug sensitivity screens, and proteotoxicity assays. Applications include monitoring client protein stability, steroid receptor transactivation, and stress pathway analysis, supporting cancer and neurodegenerative disease research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    DNAJC7

    Gene Identifier

    NCBI Gene ID 7266

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

DNAJC7 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population that disrupts DNAJC7 gene expression. This loss-of-function model eliminates the J-domain co-chaperone, enabling study of HSP70/HSP90-mediated protein folding. The polyclonal format provides a heterogeneous pool of edited alleles for robust functional studies without single-cell cloning artifacts.

The parental HAP1 cell line is a near-haploid human hematopoietic model derived from the KBM-7 chronic myeloid leukemia line. HAP1 cells grow in suspension and have a single chromosome set, which simplifies gene editing outcomes and ensures unambiguous phenotypes. This haploid background is widely used for high-throughput genetic screens and drug sensitivity profiling.

DNAJC7 acts as a co-chaperone partnering with HSPA8 and HSP90AA1 to fold steroid hormone receptors and kinases. It is activated by HSF1 under stress and functions downstream of steroid signals to mature the glucocorticoid receptor. DNAJC7 interacts with HSP70/HSP90 complexes and regulates client protein stability; its disruption impairs the unfolded protein response and chaperone-mediated autophagy. Knockout cells exhibit reduced hormone-dependent transcription and compromised kinase maturation, offering a platform to dissect chaperone signaling.

In HAP1 cells, DNAJC7 knockout creates a fully penetrant loss-of-function model for studying proteostasis failure in a leukemic background. The absence of a second allele eliminates residual co-chaperone activity, exposing dependencies on the HSP70/HSP90 system. This setting is well-suited for testing responses to proteasome inhibitors and HSP90 antagonists, and for identifying synthetic lethal interactions in cancer cells with compromised chaperone networks.

Key applications include western blotting for client protein degradation (e.g., glucocorticoid receptor, kinases), luciferase reporter assays for steroid receptor activity, and proteotoxicity assays. RNA-seq reveals transcriptional stress responses, and proliferation assays assess fitness under proteotoxic stress. This model facilitates synthetic lethal screens to identify vulnerabilities arising from chaperone disruption. For further details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)